These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 772715)

  • 1. Electrophysiology of the nigro-putamen dopamine pathway.
    York DH
    Pharmacol Ther B; 1976; 2(1):1-7. PubMed ID: 772715
    [No Abstract]   [Full Text] [Related]  

  • 2. Lesions of the nigro-neostriatal dopamine neurons or the bulbo-spinal norepinephrine and 5-hydroxytryptamine neurons in rats: action of drugs.
    Andén NE
    Pharmacol Ther B; 1975; 1(3):371-80. PubMed ID: 772707
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stereotyped behavior and the nigro-strio-nigral system].
    Arushanian EB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(5):819-32. PubMed ID: 2866641
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulation by dopamine of adenosine cyclic 3',5'-monophosphate formation in rat caudate nucleus: effect of lesions of the nigro-neostriatal pathway.
    Krueger BK; Forn J; Walters JR; Roth RH; Greengard P
    Mol Pharmacol; 1976 Jul; 12(4):639-48. PubMed ID: 183096
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrophysiology of the nigro-caudate dopamine pathway.
    Connor JD
    Pharmacol Ther B; 1975; 1(3):357-70. PubMed ID: 817324
    [No Abstract]   [Full Text] [Related]  

  • 6. The unitary activity of the substantia nigra following stimulation of the striatum in the awake monkey.
    Feger J; Ohye C
    Brain Res; 1975 May; 89(1):155-9. PubMed ID: 807295
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of striato-nigral substance P in the regulation of the activity of the nigro-striatal dopaminergic neurons.
    Glowinski J; Michelot R; Chéramy A
    Adv Biochem Psychopharmacol; 1980; 22():51-62. PubMed ID: 6156583
    [No Abstract]   [Full Text] [Related]  

  • 8. Striato-nigro-thalamic mechanisms in the organization of behavior.
    Suvorov NF; Voilokova NL; Gorbachevskaya AI; Mikhailov AV
    Neurosci Behav Physiol; 1997; 27(1):59-67. PubMed ID: 9109117
    [No Abstract]   [Full Text] [Related]  

  • 9. Actions of papaverine and bulbocapnine on synaptic transmission in the nigro-striatal pathway in the rat.
    Gonzalez-Vegas JA
    J Physiol; 1972 Oct; 226(2):102P. PubMed ID: 4343629
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.
    Fuxe K; Ungerstedt U
    Pharmacol Ther B; 1976; 2(1):41-7. PubMed ID: 817332
    [No Abstract]   [Full Text] [Related]  

  • 11. Rotational behavior induced by unilateral electrical stimulations of nigro-striatal dopamine neurons: modification by low doses of apomorphine.
    Barghon R; Costentin JH
    Eur J Pharmacol; 1980 May; 64(1):39-46. PubMed ID: 6969658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigro-striatal pathway: stimulation-evoked release of ( 3 H)dopamine from caudate nucleus.
    Voigtlander PF; Moore KE
    Brain Res; 1971 Dec; 35(2):580-3. PubMed ID: 5135554
    [No Abstract]   [Full Text] [Related]  

  • 13. The susceptibility to acetylcholine and dopamine in the caudate nucleus of cats with chronic nigrostriatal lesions.
    Sphelmann R
    Trans Am Neurol Assoc; 1974; 99():255-7. PubMed ID: 4156892
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways.
    Michelot R; Leviel V; Giorguieff-Chesselet MF; Chéramy A; Glowinski J
    Life Sci; 1979 Feb; 24(8):715-23. PubMed ID: 86931
    [No Abstract]   [Full Text] [Related]  

  • 15. Spinal cord dopaminergic neurons: evidence for an uncrossed nigrospinal pathway.
    Commissiong JW; Gentleman S; Neff NH
    Neuropharmacology; 1979 Jun; 18(6):565-8. PubMed ID: 481709
    [No Abstract]   [Full Text] [Related]  

  • 16. Accommodation of rat nigrostriatal dopamine neurones to high frequency electrical stimulation of the median forebrain bundle: in vivo voltammetric data.
    Stamford JA; Kruk ZL; Millar J
    Neurosci Lett; 1987 Nov; 82(2):172-6. PubMed ID: 3501081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory mechanisms in the substantia nigra and the dopamine pathway.
    Straughan DW; James TA
    Int J Neurol; 1979; 13(1-4):81-93. PubMed ID: 122391
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulation of the subthalamic nucleus enhances the release of dopamine in the rat substantia nigra.
    Mintz I; Hammond C; Guibert B; Leviel V
    Brain Res; 1986 Jun; 376(2):406-8. PubMed ID: 3730844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evidence about nigro-striatal inhibition related to intrinsic GABA in the caudate nucleus deprived of dopaminergic synaptic activity.
    Feltz P
    Appl Neurophysiol; 1979; 42(1-2):47-50. PubMed ID: 222207
    [No Abstract]   [Full Text] [Related]  

  • 20. Reward-related activity in the monkey striatum and substantia nigra.
    Schultz W; Apicella P; Ljungberg T; Romo R; Scarnati E
    Prog Brain Res; 1993; 99():227-35. PubMed ID: 8108550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.